178 related articles for article (PubMed ID: 37489987)
1. Pancreatic Cyst Surveillance: Who, Why, How?
Luk L; Lowy AM; Li K; Fowler KJ; Wang ZJ; Kamel IR; Liau J
Radiology; 2023 Jul; 308(1):e222778. PubMed ID: 37489987
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Surveillance and Timeline of Progression of Presumed Low-Risk Intraductal Papillary Mucinous Neoplasms.
Kayal M; Luk L; Hecht EM; Do C; Schrope BA; Chabot JA; Gonda TA
AJR Am J Roentgenol; 2017 Aug; 209(2):320-326. PubMed ID: 28590817
[TBL] [Abstract][Full Text] [Related]
3. Imaging of pancreatic cystic lesions with confocal laser endomicroscopy: an ex vivo pilot study.
Kadayifci A; Atar M; Yang M; Fernandez-Del Castillo C; Mino-Kenudson M; Brugge WR
Surg Endosc; 2017 Dec; 31(12):5119-5126. PubMed ID: 28444494
[TBL] [Abstract][Full Text] [Related]
4. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions.
Farrell JJ
Gut Liver; 2015 Sep; 9(5):571-89. PubMed ID: 26343068
[TBL] [Abstract][Full Text] [Related]
6. Integrating Molecular Analysis into the Pathologic Evaluation of Pancreatic Cysts.
Bell PD; Singhi AD
Surg Pathol Clin; 2022 Sep; 15(3):455-468. PubMed ID: 36049828
[TBL] [Abstract][Full Text] [Related]
7. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Cystic Lesions: Diagnostic, Management and Indications for Operation. Part I.
Bauer F
Chirurgia (Bucur); 2017; 112(2):97-109. PubMed ID: 28463669
[TBL] [Abstract][Full Text] [Related]
10. Incidental Intraductal Papillary Mucinous Neoplasm, Cystic or Premalignant Lesions of the Pancreas: The Case for Aggressive Management.
El Gammal AT; Izbicki JR
Surg Clin North Am; 2018 Feb; 98(1):141-155. PubMed ID: 29191271
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
[TBL] [Abstract][Full Text] [Related]
12. The role of endoscopic ultrasound in the management of intraductal papillary mucinous neoplasms: a systematic update.
Smith LA; McKay CJ
Minerva Med; 2016 Dec; 107(6):370-380. PubMed ID: 27627636
[TBL] [Abstract][Full Text] [Related]
13. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
Munigala S; Javia SB; Agarwal B
Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
[TBL] [Abstract][Full Text] [Related]
14. Mucinous nonneoplastic cyst of the pancreas: apomucin phenotype distinguishes this entity from intraductal papillary mucinous neoplasm.
Cao W; Adley BP; Liao J; Lin X; Talamonti M; Bentrem DJ; Rao SM; Yang GY
Hum Pathol; 2010 Apr; 41(4):513-21. PubMed ID: 19954814
[TBL] [Abstract][Full Text] [Related]
15. European experts consensus statement on cystic tumours of the pancreas.
Del Chiaro M; Verbeke C; Salvia R; Klöppel G; Werner J; McKay C; Friess H; Manfredi R; Van Cutsem E; Löhr M; Segersvärd R;
Dig Liver Dis; 2013 Sep; 45(9):703-11. PubMed ID: 23415799
[TBL] [Abstract][Full Text] [Related]
16. Cystic lesions and intraductal neoplasms of the pancreas.
Fasanella KE; McGrath K
Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease.
McNicholas BA; Kotaro Y; Martin W; Sharma A; Kamath PS; Edwards ME; Kremers WK; Chari ST; Torres VE; Harris PC; Takahashi N; Hogan MC
Pancreas; 2019; 48(5):698-705. PubMed ID: 31091218
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
Henry JC; Bassi C; Giovinazzo F; Bloomston M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
[TBL] [Abstract][Full Text] [Related]
20. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).
Carmicheal J; Patel A; Dalal V; Atri P; Dhaliwal AS; Wittel UA; Malafa MP; Talmon G; Swanson BJ; Singh S; Jain M; Kaur S; Batra SK
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188318. PubMed ID: 31676330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
